Zylox-Tonbridge and GL Capital Announce Strategic Investment in LifeTech Scientific to Build a Leading Vascular and Structural Heart Intervention Platform
HANGZHOU, China, Nov. 6, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190) ("Zylox-Tonbridge") today announced a strategic investment in LifeTech Scientific Corporation (HKEX: 1302) ("LifeTech"), in partnership with GL Capital, marking a significant step...
Extrait seulement — cet éditeur protège son texte. Lisez le communiqué complet à la source.
Forfait Gratuit · Plus 29 $ CA ou Pro 99 $ CA/mois


